baber/WOPTO huggingface dataset:
Patent NZ-254035-A (NZ)
Title: Electric motor wheel with power conversion system mounted within wheel
Inventor: COUTURE PIERRE
IPC: B60K7/00
Filed: 1993-07-06
Abstract: The electric motor-wheel has an entry (40) to receive current at terminals (15) and three outputs (42) for three alternate phase currents. The currents may be polyphase. A microprocessor (44) has branches (41a,41b,41c) to control the operation and is external to the motor-wheel. A stator feeds the electric current. The stator (6) is in the shape of a cross with three arms for the phase currents and a fourth arm (13). A condenser (14) distributes to the three condensers on the arms and the microprocessor is connected to the fourth arm. The motor-wheel has two distribution output buses and a circular supply (48) connected to the arms for a high-voltage current. A rotor coaxial with and rotatably mounted about the stator has a conversion system for converting an electric input current into a variable alternating electric current and also has power electronics in the hollow portion with input terminals to receive the electric current and output terminals to generate the variable alternating electric current. The variable alternating current is supplied to the stator windings.
Patent NZ-272436-A (NZ)
Title: Postformable laminate including extensible sheet formed from wood pulp which has been subjected to mechanical treatment
Inventor: DAVID EDWARD KNOX
IPC: D21H11/00
Filed: 1995-06-26
Abstract: The laminate comprises a decorative layer (3), a core layer (4) of resin saturable paper, and an extensible sheet. The extensible sheet is prepared from wood pulp characterized by a basis weight of from about 130g/m<2> to about 505 g/m<2> (about 80 pounds/3,000 ft.<2> to about 310 pounds/3,000 ft.<2>), a tensile modulus of below 24 N/mm<2> (about 3.5 kpsi) and a cross directional stretch of from about 1 % to about 3 %. The pulp is refined wood pulp subsequently subjected to a mechanical treatment at an energy input of at least about 0.0394 kWh/kg (about 2 hp-days/ton) which imparts kinking and curling characteristics to individual pulp fibers. <IMAGE>
Patent NZ-331335-A (NZ)
Title: A roofing system involving a cleat having tabs
Inventor: MOIR GRAHAM SCOTT
IPC: E04B7/02
Filed: 1998-08-13
Abstract: Provide is a brace for a roofing system comprising a support member and at each end of the support member (6) has a cleat bracket (10) comprising a plate means, first engagement means on the pale means whereby in use the plate means is engaged with a purlin, second engagement means whereby in use the plate means is engaged with a support member positionable in use between a pair of purlins, the plate means having a side edge and the first engagement means comprising one or more tabs extending outwardly from the side edge, the tabs being shaped so as to be passable into an aperture either by sequential movement in two selected directions, or by rotation of the tabs into the aperture.  Preferably the tabs have a part lying in a plane substantially at right angles to the plane of the plate means
Patent NZ-502151-A (NZ)
Title: Toothbrush having head with peel-resistant joint
Inventor: MINTEL THOMAS EDWARD
IPC: A46B9/04
Filed: 1998-06-24
Abstract: A toothbrush having a bristle-bearing head divided into at least two sections is disclosed. The free end section, when unstressed, is normally biased to assume an angle of about 15 DEG with respect to the other, to thereby define an articulated head.  The two sections of the head have facing ends joined by a thin bridge or hinge section integral with the two head sections, the bridge or hinge forming a groove between adjacent head sections.  The upper surface of the bridge section is substantially flush with the upper surface of the head (opposite to the bristle-bearing surface).  The space between the two facing ends is filled with a soft elastomer of about 5 to about 30, preferably about 13 to about 30 Shore A hardness.  This hinge construction defines an articulated head of limited flex motion, wherein, when utilized by the average adult brusher, who applies an average brushing force of 0.5 pounds, flexes to a substantially flattened position.  According to a second aspect of the toothbrush, each end of the groove terminates in a flange at its extreme outer edge, and the groove, including the flange, is filled with an elastomer, which, due to the presence of the flange, is resistant to peel stresses caused by flexing of the hinge or joint.
Patent NZ-502315-A (NZ)
Title: Operator's station for a lift truck including three position seat assembly
Inventor: HENSHAW ROBERT JOSEPH
IPC: B60N2/38
Filed: 1998-08-26
Abstract: An improved operator's station (70) includes an improved three position seat assembly (90) which allows the operator to stand, perch or sit while maintaining the operator's eyes at essentially the same vertical level. The seat assembly includes a back rest (95), a seat (100) that may be raised and lowered, and a movable shelf (not shown) or perch positioned between the back rest and the seat. In a stand mode of operation, the seat is lowered and the shelf is raised; in a perch mode of operation, the shelf is lowered to provide a partial support for the weight of the operator; and, in a sit mode of operation, the seat is raised for substantially full support of the weight of the operator and the shelf is raised to be flush with the back rest. Two sets of foot pedals (120, 125; 130, 135) are provided in the improved operator's station (70). A first set of pedals (120, 125) is on the floor and includes a brake pedal (120) and a power pedal (125). These pedals are operated when the operator is either standing or perching. A second set of pedals (130, 135) is raised above the first set of pedals (120, 125) and positioned to be operated when the operator is in the seated position, although the operator may optionally also use one or the other of the raised pedals in either the stand or perch modes of operation, thus providing additional flexibility in operating positions.
Patent NZ-503646-A (NZ)
Title: Method and apparatus for treating petrol with magnetic fields
Inventor: FORREST LINDSAY WARREN
IPC: F02M27/04
Filed: 1997-07-28
Abstract: A method of treating petrol comprising subjecting the petrol to a plurality of magnetic fields of field strengths up to 4000 gauss in rapid succession for at least one second.  At least one pair of adjacent fields are of different field strengths or of a different field polarity.
Patent NZ-504752-A (NZ)
Title: Hydrophobically-modified protein compositions (particularly hedgehog proteins)
Inventor: PEPINSKY BLAKE R
IPC: A61K38/17
Filed: 1998-12-03
Abstract: An isolated protein including an N-terminal amino acid and a C-terminal amino acid wherein the protein is selected from: a) a protein with an N-terminal cysteine that is appended with at least one hydrophobic moiety b) a protein with an N-terminal amino acid that is not a cysteine appended with at lest one hydrophobic moiety and c) a protein with at lest one hydrophobic moiety substituted for the N-terminal amino acid with the proviso that when the isolated protein is a naturally occurring fragment of a hedgehog polypeptide , the hydrophobic moiety is other than a palmitoyl group at the N-terminus of the polypeptide. The protein in the absence of the hydrophobic moiety binds to a receptor or coreceptor and the hydrophobic moiety does not substantially affect binding affinity of the protein to the receptor or coreceptor. The protein may be in the form A-Cys-[Sp]-B-[Sp]-X where A is a hydrophobic moiety, Cys is a cysteine, [Sp] is an optional spacer peptide sequence, B is a plurality of amino acids, which protein binds a receptor or coreceptor, or another spacer peptide sequence and X is optionally another hydrophobic linked to an amino acid of B with the same proviso as above. Also described is a method to generate a multivalent protein complex comprising linking in the presence of a vesicle a hydrophobic moiety to a n N-terminal cysteine of a protein, wherein the protein in the absence of the hydrophobic moiety does not substantially affect binding affinity to the receptor or coreceptor and a method to modify a protein to enhance its biological activity. Also described is the use of the proteins in the manufacture of a medicament suitable for the treatment of neurological disorder.
Patent NZ-505987-A (NZ)
Title: Crystalline organic compounds retaining crystalline character and uniform shape on storage in aqueous medium for at least one month
Inventor: SAVOIR JOHN CLAUDE
IPC: A61K9/18
Filed: 1999-02-10
Abstract: A plurality of storage stable particles of uniform shape consists essentially of a plurality of allotropic organic compounds. Each of the allotropic organic compounds consists essentially of a uniform crystalline character and a plurality of crystalline domains. The organic compounds retain their crystalline character and the particles retaining their uniform shape on storage in aqueous media for at least about one month. A method for effecting solid state crystallization of an allotropic molecular organic compound in a particle of uniform size and shape comprises creating a formulation consisting essentially of an allotropic organic compound of mixed crystalline or both crystalline and amorphous form. The formulation is then fabricated into a plurality of particles of uniform shape. The particles are exposed to an atmosphere containing vapor of a solvent of the allotropic organic compound for a time sufficient to effect a solid state crystallization of the particles and then the particles are recovered. The allotropic organic compound in the recovered particles is a of a uniform crystalline structure, with the particles retaining their shape and can retain their shape on storage in aqueous media for at least one month. Preferably the allotropic organic compound is a sterol or steroid.
Patent NZ-507793-A (NZ)
Title: Recombinant virus expressing foreign DNA encoding feline CD80, feline CTLA-4 or feline CD86 and uses thereof
Inventor: WINSLOW BARBARA J
IPC: C12N15/869
Filed: 1999-04-30
Abstract: A recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a protein. The protein which is encoded is selected from the groups consisting of a feline CD28 protein or an immunogenic portion thereof, a feline CD80 protein or an immunogenic portion thereof, a feline CD86 protein or an immunogenic portion thereof, or a feline CTLA-4 protein or an immunogenic portion thereof. The protein is capable of being expressed when the recombinant virus is introduced into an appropriate host. The recombinant virus may also further comprise a foreign nucleic acid encoding an immunogen derived from a pathogen. Also included are recombinant viruses which are capable of enhancing or suppressing an immune response in a feline.
Patent NZ-511420-A (NZ)
Title: Cheese production wherein bacterial fermentation and/or enzymatically catalysed coagulation is avoided
Inventor: HUANG I-LO
IPC: A23C19/068
Filed: 1999-11-08
Abstract: Described is a simplified, rapid method which is suitable for making a variety of cheese and cheese products, including natural and processed cheese, in a single installation with common equipment.  In particular, a method of making cheese is described, comprising the steps of: (a) concentrating milk or a reconstituted dry milk, having its pH adjusted to a range of from about 5.0 to 6.8, by ultrafiltration and diafiltration to produce a retentate; (b) supplementing the retentate with a protein concentrate or isolate and, optionally, fat and/or flavour; and © heating the mixture to produce a smooth consistency.
Patent NZ-511790-A (NZ)
Title: Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
Inventor: KLING KAREN
IPC: C07D221/18
Filed: 1999-12-13
Abstract: A method of treating organic erectile dysfunction, particularly vasculogenic erectile dysfunction comprises administering to a male in need of such treatment a therapeutically effective amount of apomorphine or a pharmaceutically acceptable salt or pro-drug thereof.
Patent NZ-515619-A (NZ)
Title: Inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
Inventor: AUGELLI-SZAFRAN CORINNE ELIZAB
IPC: C07D401/12
Filed: 2000-05-31
Abstract: Compounds of formula (I) wherein; X is phenyl or substituted phenyl; Y is phenyl, substituted phenyl, pyridyl, or substituted pyridyl. These compounds are useful in the treatment of AlzheimerÆs disease.
Patent NZ-518837-A (NZ)
Title: Continuous haulage system
Inventor: PIETSCH MICHAEL
IPC: B65G15/42
Filed: 2000-11-06
Abstract: A continuous haulage system, including a belt (1) adapted to convey material, said belt (1) being suspended from supporting means (3a, 3b) by hanging members (4a, 4b) located along each opposing longitudinal edge of said belt, wherein the hanging member (4a, 4b) has a hook-shaped cross- section.
Patent NZ-520086-A (NZ)
Title: Oscillating hand tool with intermediate mounting platen to prevent free rotation of sanding platen
Inventor: WALKER ANDREW
IPC: B24B23/04
Filed: 2002-07-09
Abstract: The powered oscillated hand tool is provided having  a housing  and a drive unit contained in the housing having  a first  drive  shaft 7 and a bearing 15 mounted eccentrically relative  to  the first drive shaft 7. A second drive  shaft 14  extends from the bearing 15 and mountable thereon  is  a mounting platen 90 which is secured by means of one or  more flexible legs 80 to the housing. The mounting platen 90  has coupling  means  95  which are securable with  corresponding coupling  means  on  a  first sanding  platen  20  which  is secured  against free rotation about the second drive  shaft when mounted thereon.
Patent NZ-523128-A (NZ)
Title: Anthelmintic formulations containing avermectins and or milbemycins
Inventor: RAZZAK MAJID HAMEED ABDUL
IPC: A61P33/10
Filed: 2002-12-12
Abstract: A method of manufacturing a stable multiple active veterinary formulation comprising the steps of: a) Dissolving a first active in a solvent b) Sorbing the solvent containing active composition on to a sorbing medium; and c) Dispersing the sorbing medium loaded with the solvent composition in a liquid, wherein the liquid contains at least one further active dissolved or suspended therein. The first active may be a lipophilic active selected from the group including the avermectins and the milbemycins. The liquid may be an aqueous vehicle and the solvent may be selected form oils and organic solvents. The at least one further active may be selected from the group including vitamins, minerals, anthelmintics or antigens. The sorbing medium may be selected from magnesium aluminmetasilicate, cellulose, microcrystalline cellulose, distomaceous earth, montmorillonite, betonite, titanium dioxide, amorphous silicon dioxide, colloidal silicon dioxide (Aerosil), calcium carbonate, talc (SiO2 + MgO), attapulgite (silicon, aluminium and iron oxides clay), kaolin (aluminium silicate) preferable Aerosil, more preferably Aerosil R972. The stable multiple active veterinary formulation produced as a result of the above method is also described. The disclosed formulation is useful in the treatment of a non-human animal.
Patent NZ-528792-A (NZ)
Title: Carprofen composition
Inventor: LAU KAI KIN
IPC: A61K31/403
Filed: 2003-10-09
Abstract: A stable solvent-based composition comprising: a) a therapeutically effective amount of carprofen; b) one or more polyols in an amount of from 20 to 998g/L; c) one or more stabilizing agents in an amount of from 0.1 to 50g/L; and d) one or more co-solvents in an amount of from 0 to 500g/L.
Patent NZ-528905-A (NZ)
Title: Pyrrolo[2,3-d]pyrimidine compounds
IPC: C07D487/02
Filed: 2000-11-23
Abstract: Disclosed is a method for the inhibition of the enzyme protein kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, xeno transplantation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, Leukemia and other autoimmune diseases in a non-human mammal, comprising administering a compound of formula (I) wherein R1, R2 and R3 are defined herein. (62) Divided Out of 518884
Patent NZ-530126-A (NZ)
Title: Apparatus and method for the treatment of waste
Inventor: AMES ROY VICTOR
IPC: B07B13/00
Filed: 2002-05-03
Abstract: The present invention relates to a treatment system for treating primary waste onsite. The treatment system includes a separation cone which separates the solid waste from the liquid waste and the different wastes are subsequently treated separately. The solid wastes are subject to aerobic decomposition by worms and other suitable organisms while liquid wastes are filtered through alternate layers of coarse and fine filter media. The resulting treated liquid can be recirculated or pumped out of the system for other purposes or further treatment. The treatment system is designed as a compact modular system and maybe used for the treatment of domestic human waste. (61) Addition to 530125
Patent NZ-531660-A (NZ)
Title: Wind turbine power module mounted on the tower foundation
Inventor: WOBBEN ALOYS
IPC: F03D9/25
Filed: 2002-09-12
Abstract: A method for constructing a wind energy plant and a wind energy plant. The aim is to provide a method for constructing wind energy plants at lower expenses and more rapidly. According to the method for constructing a wind energy plant that comprises a tower that is based on a foundation and an electrical power module, the power module is mounted on the tower foundation before the tower itself is constructed. The power module comprises a transformer and optionally an inverter or other electrical installations, such as for example switch cabinets, that are provided for controlling the wind energy plant and/or for guiding the electrical power that is provided by the generator of the wind energy plant and that is fed to a network.
Patent NZ-533027-A (NZ)
Title: Screw
Inventor: KUO-TAI SU
Filed: 2004-05-19
Abstract: The present invention provides a screw comprising of a head, a shank under the head in a whole body, and a thread helically built upon the outside trunk of the shank; wherein, said thread projected from the circular trunk of the shank is consisted of an upper flight, a low flight, and a peak on the joint line of the upper and low flights, and an even number of axial slots formed on the thread. The feature is that every axial slot is bevelled with a back angle to form a sheared section from the upper flight to the low flight to form a cutting edge for facilitating to rapid fastening with smaller tapping torque as tapping in.
Patent NZ-533356-A (NZ)
Title: Vaccine and method for treatment of motor neurone diseases
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61P25/28
Filed: 2002-12-05
Abstract: Described is the use of an active agent from the group consisting of Cop 1, a Cop 1-related peptide, and a Cop 1-related polypeptide, for the preparation of a vaccine for reducing disease progression, and/or protection of motor nerve degeneration, and/or protection from glutamate toxicity in motor neurone disease (MND) patients.
Patent NZ-533628-A (NZ)
Title: 3-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof
Inventor: AVERETT DEVRON R
IPC: C07H19/24
Filed: 2002-11-27
Abstract: 3- beta -D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides of general Formula I and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.
Patent NZ-534539-A (NZ)
Title: 2-oxazolamines and their use as 5-HT2B receptor antagonists
Inventor: OXFORD ALEXANDER WILLIAM
IPC: A61K31/422
Filed: 2003-02-11
Abstract: A compound of formula I is described wherein: One of R1 and R4 is selected from H, optionally substituted C1-6alkyl, C3-7cycloalkyl, C3-7 cycloalkyl-C1-4alkyl and phenyl C1-4alkyl and the other of R1 and R4 is an optionally substituted C9-14aryl group, wherein the C9-14aryl group has at least 2 fused rings R2 and R3 are selected from R, R', SO2R, C(=O)R, (CH2)nNR5R6, where n is 1 to 4 and R5 and R6 is selected from H and R where R is optionally substituted C1-4alkyl, and R' is optionally substituted phenyl-C1-4alkyl. The compounds can be used in the preparation of medicaments for the treatment of conditions alleviated by antagonism of 5-HT2B receptors.
Patent NZ-535534-A (NZ)
Title: Self-metering dispensing device
Inventor: SCHILLER STEVEN E
IPC: B65D83/16
Filed: 2003-02-27
Abstract: A self metering dispensing device for dispensing a predetermined quantity of material from an aerosol container. First and second actuating members (31, 18) are pivotally connected to a housing (12) for the container and a nozzle actuating member (36) is connected to the first actuating member. A pneumatic member in the form of a cylinder (28) with a piston or a telescoping valve is operatively associated with the first and second actuating members. A compressive force placed on the second actuating member (18) causes the nozzle activating member to contact the container (62) valve to dispense product from the container. A controlled metering of product is produced by an air (42) regulator connected to the pneumatic member.